Toro Analysts Cut Their Forecasts After Q2 Results

The Toro Company (TTC) reported mixed Q2 results with sales of $1.32 billion missing estimates, while adjusted EPS of $1.42 beat expectations. Consequently, Toro lowered its FY25 adjusted EPS guidance to $4.15-$4.30 and expects net sales growth to be flat to -3%. Following the announcement, several analysts adjusted their price targets, with Northland Capital Markets downgrading the stock, contributing to a 6.5% dip in Toro shares to $68.51.

Analysis

The Toro Company (TTC) reported mixed second-quarter fiscal 2025 results, with a 2% year-over-year sales decrease to $1.32 billion, missing the consensus estimate of $1.35 billion, while adjusted EPS of $1.42 slightly exceeded the $1.40 consensus, marking a 1% Y/Y increase. Significantly, Toro has lowered its full-year 2025 guidance; adjusted EPS is now expected to be between $4.15 and $4.30, down from the previous range of $4.25-$4.40 and below the $4.31 consensus. The company also revised its FY25 net sales growth outlook from flat to 1% to a range of flat to -3%, signaling anticipated difficulties. Chairman and CEO Richard M. Olson stated the company is taking "decisive steps to strategically position the company to navigate near-term headwinds" and expressed confidence in managing controllable factors. The market reacted negatively to this outlook, with TTC shares falling 6.5% to $68.51. Analyst sentiment reflected this caution: Baird maintained a Neutral rating but lowered its price target from $85 to $82; Northland Capital Markets downgraded Toro from Outperform to Market Perform, reducing its price target from $100 to $80; and Raymond James, while maintaining an Outperform rating, also lowered its price target from $95 to $90.

Key Decisions for Investors

• Investors should carefully consider The Toro Company's revised FY25 guidance, particularly the lowered sales outlook of flat to -3% and adjusted EPS of $4.15-$4.30, which indicates expected operational headwinds and has already prompted negative market and analyst reactions.
• The 6.5% decline in share price to $68.51, coupled with multiple analyst price target reductions and a downgrade from Northland Capital Markets, suggests increased investor caution; existing holders may wish to review their positions in light of these developments.
• Monitor future disclosures for evidence of the company's success in navigating the stated "near-term headwinds" and achieving its revised targets, as this will be critical for a potential re-rating of the stock.